Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
7d
InsideHook on MSNNew FDA Approval Could Transform Pain ManagementIt’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results